LOCALLY ADVANCED GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Clinical trials for LOCALLY ADVANCED GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy aims to shrink stomach tumors before surgery
Disease control Recruiting nowThis study tests whether giving low-dose radiation, an immunotherapy drug (tirelizumab), and chemotherapy (SOX) before surgery can help people with advanced stomach or gastroesophageal junction cancer. The goal is to see if this combination can completely eliminate the tumor by t…
Matched conditions: LOCALLY ADVANCED GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated May 17, 2026 08:25 UTC
-
New drug cocktail aims to shrink stomach tumors before surgery
Disease control Recruiting nowThis study tests whether adding a new immunotherapy combination (iparomlimab and tuvonralimab) to standard chemotherapy can better shrink locally advanced stomach or gastroesophageal junction cancer before surgery. About 96 adults with stage T3N+ or T4a cancer that hasn't spread …
Matched conditions: LOCALLY ADVANCED GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated May 14, 2026 12:06 UTC